These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25978922)

  • 1. [Serum tumour markers in asymptomatic patients].
    Torné Cachot J; Baucells Azcona JM; Blanch Falp J; Blancas Altabella D
    Med Clin (Barc); 2015 Oct; 145(7):319-20. PubMed ID: 25978922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Search for circulating tumor cells: Seriously, a real cancer screening tool?].
    Hofman P
    J Mal Vasc; 2015 Dec; 40(6):335-7. PubMed ID: 26526763
    [No Abstract]   [Full Text] [Related]  

  • 3. [Impact of the implementation of a protocol for the adequate and safe use of tumor markers].
    Mérida de la Torre FJ; Moreno Campoy EE; Martos Crespo F
    Med Clin (Barc); 2015 Dec; 145(12):526-8. PubMed ID: 26169333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for prostate cancer: prostate-specific antigen testing is not effective.
    Hitzeman N; Molina M
    Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
    [No Abstract]   [Full Text] [Related]  

  • 5. 'Liquid biopsy' for cancer promises early detection.
    Kaiser J
    Science; 2018 Jan; 359(6373):259. PubMed ID: 29348215
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer screening through a multi-analyte serum biomarker panel during health check-up examinations: Results from a 12-year experience.
    Wen YH; Chang PY; Hsu CM; Wang HY; Chiu CT; Lu JJ
    Clin Chim Acta; 2015 Oct; 450():273-6. PubMed ID: 26344337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase.
    Di Gioia D; Stieber P; Schmidt GP; Nagel D; Heinemann V; Baur-Melnyk A
    Br J Cancer; 2015 Mar; 112(5):809-18. PubMed ID: 25647014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection.
    Pantel K
    PLoS Med; 2016 Dec; 13(12):e1002205. PubMed ID: 28027295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types.
    Ren S; Zhang Z; Xu C; Guo L; Lu R; Sun Y; Guo J; Qin R; Qin W; Gu J
    Cell Res; 2016 Aug; 26(8):963-6. PubMed ID: 27364686
    [No Abstract]   [Full Text] [Related]  

  • 10. Too Much Medicine: Time to Stop Indiscriminate Cancer Screening.
    Ng RC
    Ann Acad Med Singap; 2015 Jun; 44(6):194-6. PubMed ID: 26292946
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients Present with More Advanced Prostate Cancer since the USPSTF Screening Recommendations.
    Barry MJ; Nelson JB
    J Urol; 2015 Dec; 194(6):1534-6. PubMed ID: 26384450
    [No Abstract]   [Full Text] [Related]  

  • 12. Save your life: cancer screening is oversold. Know the tests to get--and those to skip.
    Consum Rep; 2013 Mar; 78(3):28-33. PubMed ID: 23556197
    [No Abstract]   [Full Text] [Related]  

  • 13. Grail to pour $1 billion into blood test to detect early cancer.
    Sheridan C
    Nat Biotechnol; 2017 Feb; 35(2):101-102. PubMed ID: 28178244
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
    Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
    Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An individual reference limit for 'early' diagnosis of metastatic breast cancer during postoperative follow-up.
    Nicolini A; Ferrari P; Fulceri F; Carpi A; Rossi G
    Biomark Med; 2015; 9(4):307-17. PubMed ID: 25808435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy: still early days for early detection.
    Watts G
    Lancet; 2018 Jun; 391(10140):2593-2594. PubMed ID: 30070213
    [No Abstract]   [Full Text] [Related]  

  • 17. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
    Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
    Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catching up with the evidence.
    Hickner J
    J Fam Pract; 2013 Mar; 62(3):119. PubMed ID: 23520580
    [No Abstract]   [Full Text] [Related]  

  • 19. [PROBASE study - optimizing PSA screening].
    Setton J
    Aktuelle Urol; 2013 Nov; 44(6):431. PubMed ID: 24281932
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biomarker screening for early detection of cancer].
    Wiedemann GJ
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):43-5. PubMed ID: 23250696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.